Blood Adv.2020 Jul;4(13):3136-3140. 461289. doi: 10.1182/bloodadvances.2020002308.
ターゲットとしたFGFR阻害により、FGFR1が駆動する好酸球症を有する骨髄性新生物において、持続的な寛解が得られる
Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia.
- Monica Kasbekar
- Valentina Nardi
- Paola Dal Cin
- Andrew M Brunner
- Meghan Burke
- Yi-Bin Chen
- Christine Connolly
- Amir T Fathi
- Julia Foster
- Molly Macrae
- Steven L McAfee
- Kristin McGregor
- Rupa Narayan
- Aura Y Ramos
- Tina T Som
- Meghan Vartanian
- Robb S Friedman
- Karim A Benhadji
- Gabriela S Hobbs
PMID: 32649766 DOI: 10.1182/bloodadvances.2020002308.
抄録
抄録はありません
